K. Searle

Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases

G. Enders, M. Enders, I. Zoellner, 2004, Prenatal diagnosis.

Acute parvovirus B19 infection in pregnant women—An analysis of serial samples by serological and semi-quantitative PCR techniques

G. Enders, G. Schalasta, S. Wallat, 1998, Infection.

Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports.

D. Haffner, J. Dötsch, K. Brown, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Maternal serum alpha‐fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without fetal complications

K. Searle, Klemens Komischke, Gisela Enders, 1997, Prenatal diagnosis.

Seroprevalence of parvovirus B19 NS1‐specific IgG in B19‐infected and uninfected individuals and in infected pregnant women

S. Modrow, H. Wolf, G. Enders, 2000, Journal of medical virology.

Parvovirus B19 diagnosis in pregnant women — quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum

G. Enders, K. Searle, C. Guilliard, 2005, Infection.

The role of inflammation in preterm birth—focus on periodontitis

M. Klebanoff, K. Searle, 2006, BJOG : an international journal of obstetrics and gynaecology.

Development of antibodies to the nonstructural Protein NS1 of parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: Implications for pathogenesis doubtful

G. Enders, G. Schalasta, K. Searle, 1998, Journal of Medical Virology.